title: Corticosteroids in preventing severe lupus flares: do all patients have the same risk? Comment on the article by Tseng et al.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Callejas-Rubio
authors.forename: Raquel
authors.initials: R
authors.lastname: Rios-Fernández
authors.forename: Cristina
authors.initials: C
authors.lastname: Tomás-Jiménez
authors.forename: Norberto
authors.initials: N
authors.lastname: Ortego-Centeno
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004247:DNA / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000888:Antibodies, Anti-Idiotypic; D018501:Antirheumatic Agents; D006886:Hydroxychloroquine; D004247:DNA; D011241:Prednisone